most recent vaers report

vaers data csv and compressed (zip) files are available for download in the table below. for information about vaers data, please view the vaers data use guide [pdf – 310kb], which contains the following information: select the desired time interval to download vaers data. each data set is available for download as a compressed (zip) file or as individual csv files. each compressed file contains the three csv files listed for a specific data set. note for internet explorer users: due to security reasons in your browser’s settings you might be prompted to select “show restricted content” in order to view the .csv file as a spreadsheet. vaers is co-sponsored by the centers for disease control and prevention (cdc), and the food and drug administration (fda), agencies of the u.s. department of health and human services (hhs).

close ongoing surveillance in the safety of covid-19 vaccines is critical and will inform the use of individual covid-19 vaccines. this study assessed the ae reporting of the three available covid-19 vaccines in vaers since the first administration on 14 december 2020 and compared the ae reporting among individual covid-19 vaccines as of 8 october 8 2021. vaccine adverse event reporting system, co-managed by the cdc and fda, is a nationwide early warning system aimed to detect potential safety issues for all vaccines approved in the united states (30). to compare the safety and ae reporting of covid-19 vaccines with all other vaccines, we calculated the reporting odds ratio (ror) and 95% confidence intervals (95% cis) for each assessed ae outcome during the same period between 14 december 2020 and 8 october 2021 for all three covid-19 vaccines combined together and for each individual covid-19 vaccine. the results of the breslow-day statistics to compare rors of seven serious ae outcomes for individual covid-19 vaccines with all other vaccines are shown in table 5. we found that the signals of disproportionate reporting for the four serious ae outcomes (i.e., er visits, hospitalization, life-threatening events, and disability) with each individual covid-19 vaccine were all different from another individual covid-19 vaccine (p < 0.05). nevertheless, the large amount of ae reports for covid-19 vaccines in vaers provides a great opportunity for practitioners, policymakers, and researchers to timely monitor the safety of covid-19 vaccines. the most commonly reported aes of covid-19 vaccines were mild. the preliminary evidence generated from this study needs to be verified through active surveillance systems in order to inform the selection of individual covid-19 vaccines and guide current and upcoming covid-19 vaccination in the united states and around the world. safety and efficacy of the bnt162b2 mrna covid-19 vaccine.

acceptability of a covid-19 vaccine among adults in the united states: how many people would get vaccinated? first month of covid-19 vaccine safety monitoring – united states, december 14, 2020-january 13, 2021. mmwr morb mortal wkly rep. (2021) 70:283–8. active surveillance of vaccine safety: a system to detect early signs of adverse events. doi: 10.15585/mmwr.mm7031e1 30. shimabukuro tt, nguyen m, martin d, destefano f. safety monitoring in the vaccine adverse event reporting system (vaers). safety of covid-19 vaccines administered in the eu: should we be concerned? (2021): doi: 10.1101/2021.07.19.21260714 42. buckner jh, chowell g, springborn mr. dynamic prioritization of covid-19 vaccines when social distancing is limited for essential workers. comparative safety of mrna covid-19 vaccines to influenza vaccines: a pharmacovigilance analysis using who international database. doi: 10.1001/jama.294.21.2720 citation: zou c, xue x and qian j (2022) characteristics and comparison of adverse events of coronavirus disease 2019 vaccines reported to the united states vaccine adverse event reporting system between 14 december 2020 and 8 october 2021. front.

vaers accepts reports of adverse events that occur following vaccination. anyone, including healthcare providers, vaccine manufacturers, and the public can contact your healthcare provider. report an adverse event using the vaers online form or the downloadable pdf. new! important: if you are experiencing a medical each compressed file contains the three csv files listed for a specific data set. last updated: . ( * data contains vaers reports processed as, .

more than 589 million doses of covid-19 vaccines were administered in the united states from , through . during this time, vaers this online database provides a nationwide mechanism by which vaers reports are made available to the public and may be reviewed and analyzed. the vaers data the number of deaths reported after a covid-19 vaccination as of 24 may—4863—represents just 0.0017% of more than 285 million doses of vaccine given, the agency, .

When you try to get related information on most recent vaers report, you may look for related areas. .